Mark Kirby is the Executive Chairman of Eykona Technologies Ltd.
Mark has 25+ years experience in emerging healthcare companies. He joined Medic-Aid Ltd at an early stage and was responsible for significant growth of the company. He led an MBO from the original owners in 1994 and subsequently floated the company on the full list of the London Stock Exchange as Profile Therapeutics plc in March 2000. The company was sold to Respironics in July 2004. Since that time Mark has worked with a number of medical / pharmaceutical companies and is currently Chairman of Glide Pharma, a specialty pharmaceutical company and Non Executive Director of Nigaard A/S, a Norwegian specialty pharmaceutical company.
|
|
|